PUBLISHER: GlobalData | PRODUCT CODE: 1663600
PUBLISHER: GlobalData | PRODUCT CODE: 1663600
Inferior Vena Cava Filters (IVCF) Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to lungs. The filter is inserted inside a large vein called the inferior vena cava (which carries blood from lower extremities to the heart). IVC filter traps blood clots before it reaches to the lungs. It is commonly used as a preventive measure in cases where Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) has been diagnosed or as a prophylactic device in cases where the risk of developing Venous Thromboembolism (VTE) is high and there is a contraindication for anticoagulants. Usage of IVC filters can prevent PE, but it does not restrict blood clot formation. IVC filters are made of non-ferromagnetic materials [Cobalt Chromium Alloy, Stainless Steel, Titanium, Nickel-Titanium (Nitinol)].
Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with intervention volumes. The interactive excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Inferior Vena Cava Filters (IVCF) and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Mermaid Medical A/S, Becton Dickinson and Co, Argon Medical Devices Inc, Cook Group Inc, Cardinal Health Inc, B. Braun Melsungen AG, LifeTech Scientific Corp, Merit Medical Systems Inc, ALN implants chirurgicaux, Boston Scientific Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -